1. Home
  2. NVAX vs PFBC Comparison

NVAX vs PFBC Comparison

Compare NVAX & PFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • PFBC
  • Stock Information
  • Founded
  • NVAX 1987
  • PFBC 1991
  • Country
  • NVAX United States
  • PFBC United States
  • Employees
  • NVAX N/A
  • PFBC N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • PFBC Major Banks
  • Sector
  • NVAX Health Care
  • PFBC Finance
  • Exchange
  • NVAX Nasdaq
  • PFBC Nasdaq
  • Market Cap
  • NVAX 1.4B
  • PFBC 1.1B
  • IPO Year
  • NVAX 1995
  • PFBC 1998
  • Fundamental
  • Price
  • NVAX $7.19
  • PFBC $93.21
  • Analyst Decision
  • NVAX Hold
  • PFBC Hold
  • Analyst Count
  • NVAX 8
  • PFBC 3
  • Target Price
  • NVAX $11.38
  • PFBC $104.67
  • AVG Volume (30 Days)
  • NVAX 4.2M
  • PFBC 77.7K
  • Earning Date
  • NVAX 11-06-2025
  • PFBC 10-20-2025
  • Dividend Yield
  • NVAX N/A
  • PFBC 3.23%
  • EPS Growth
  • NVAX N/A
  • PFBC N/A
  • EPS
  • NVAX 2.07
  • PFBC 9.87
  • Revenue
  • NVAX $1,064,651,000.00
  • PFBC $271,347,000.00
  • Revenue This Year
  • NVAX $59.49
  • PFBC $3.09
  • Revenue Next Year
  • NVAX N/A
  • PFBC $3.60
  • P/E Ratio
  • NVAX $3.47
  • PFBC $9.40
  • Revenue Growth
  • NVAX 20.27
  • PFBC 4.21
  • 52 Week Low
  • NVAX $5.01
  • PFBC $71.90
  • 52 Week High
  • NVAX $11.55
  • PFBC $99.78
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.23
  • PFBC 56.99
  • Support Level
  • NVAX $7.08
  • PFBC $91.24
  • Resistance Level
  • NVAX $7.90
  • PFBC $92.16
  • Average True Range (ATR)
  • NVAX 0.37
  • PFBC 1.75
  • MACD
  • NVAX -0.12
  • PFBC 0.23
  • Stochastic Oscillator
  • NVAX 7.17
  • PFBC 78.44

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About PFBC Preferred Bank

Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.

Share on Social Networks: